Analysis of clinical data revealed a significant correlation between high GPR56 levels and poor outcome in acute myeloid leukemia, ovarian cancer, and colorectal cancer (CRC) (10, 11, 12, 13, 14, 15). Here, ADGRG1 is linked to colorectal carcinoma.